Rebalix
Logo XtrackersXtrackers · sheet of 10 September 2026
ETF sheet · official issuer and register data

Xtrackers S P 500 Equal Weight Scored Screened UCITS ETF 1c

IE0004MFRED4 · IE0004MFRED4 · USD · domicile Ireland
Equity · United States · Large cap · Risk parity · Sustainable / ESGSFDR art. 8
Index tracked: S&P 500 Equal Weight Scored & Screened Index (USD)
TER
0.17%+ trans. 0.07%
Fund size
3.1 bn EUR
Tracking difference
+0.15%3-year avg
🇮🇹 tax rate
white list not published
Replication
Physical
Income
Accumulating
Launch 6 Dec 2022 · costs from the KID as of 2 Sept 2026 · 293 securities held · 9 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The fund is passively managed. INVESTMENT OBJECTIVE: The aim is for your investment to reflect the performance, before fees and expenses, of the S&P 500 Equal Weight Scored & Screened Index (index) which is designed to reflect the equal weighted performance of the shares of large capitalisation companies representing all major US industries and which meet certain environmental, social and governance (ESG) criteria. DESCRIPTION OF INDEX: The index is based on the S&P 500 Equal Weight Index (Parent Index) which is an equal weighted index reflecting the…

Performance since series start (in euro) — base 100

6 Dec 20228 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
202320242025202615093146
High 150 (14 Aug 2026) · low 93 (23 Mar 2023) · last 146. Past performance is not indicative of future results.

Returns in euro

1 year+20.9%
3 years+43.4%
5 yearsseries too young
10 yearsseries too young
Since series start+46.5%

Risk · 1 / 3 / 5 years

Volatility (ann.)11.47%13.93%
Max drawdown−7.83%−19.03%
Sharpe1.440.88
Sortino2.191.30
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · IE0004MFRED4 · IE0004MFRED41
RebalixIE0004MFRED4 · IE0004MFRED4 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+12.66%+12.51%+0.15%
2024+11.91%+11.79%+0.12%
2023+13.81%+13.63%+0.18%

Holdings

Portfolio as declared by the issuer · 2 Sept 2026 · 293 securities · top-10 weight = 5.4%
Top holdingsWeight
MODERNA1.1%
CHARLES RIVER LABORATORIES INTERNA0.5%
SALESFORCE0.5%
MARATHON PETROLEUM0.5%
WORKDAY CLASS A0.5%
GLOBAL PAYMENTS INC0.5%
EXPEDIA GROUP0.5%
PALO ALTO NETWORKS0.5%
REGENERON PHARMACEUTICALS0.5%
SERVICENOW0.5%
Countries (% of fund)
United States98.2%Ireland1.6%Netherlands0.3%
Sectors (% of fund)
Financials16.6%Industrials15.9%Information Technology15.1%Health Care14.0%Consumer Discretionary9.0%

Listing venues

ESMA register (FIRDS) and official exchange lists
XZEW · Borsa Italiana (ETFplus), Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 19 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · etf.dws.com/download/asset/ea050a37-1a14-45e7-bfa4-481a6d59f9af
Factsheet · etf.dws.com/download/asset/442331c9-8c14-4f0f-80c5-60bea113aa0d
Prospectus · etf.dws.com/download/asset/25f159fa-a123-4a77-9751-682976c15095
The live sheet, always up to date
rebalix.com/en/etf/IE0004MFRED4
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · IE0004MFRED4 · IE0004MFRED42